| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/11/2000 | US6086897 Isolation peptide from a protein allergen of dermatophagoide |
| 07/11/2000 | US6086852 Conformational isomers of toluidine blue o, and n-demethylation derivatives; synthesis, in which a complexing agent is introduced prior to the last stage of oxidation of a three-step synthesis from n,n-dimethyl-p-phenylenediamine |
| 07/11/2000 | US6086851 Interdigitation-fusion (if) liposome prepared by combining sized liposomes and a symmetrical saturated phospholipid with an amount of an inducer to induce fusion and interdigitation to form a gel, incubating the if gel to form an if liposome |
| 07/11/2000 | US6086850 Calcitonin receptor binding reagents |
| 07/11/2000 | US6086573 Method of removing thrombosis in fistulae |
| 07/11/2000 | US6086540 Methods of ultrasound imaging using echogenically persistent contrast agents |
| 07/11/2000 | CA2188385C Dosage forms and method for ameliorating male erectile dysfunction |
| 07/11/2000 | CA1341050C Neurite growth regulatory factors |
| 07/06/2000 | WO2000039464A1 Peristaltic compressors adapted to non-relaxing compression of polarised gas |
| 07/06/2000 | WO2000038738A1 Blood pool agents for nuclear magnetic resonance diagnostics |
| 07/06/2000 | WO2000038579A2 Device and method for safe location and marking of a cavity and sentinel lymph nodes |
| 07/06/2000 | WO2000038536A2 Inhibitors of the bitter taste response |
| 07/06/2000 | WO1999063115A9 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 07/06/2000 | WO1999055383A3 Improvements in or relating to diagnostic/therapeutic agents |
| 07/06/2000 | CA2715331A1 Device and method for safe location and marking of a cavity and sentinel lymph nodes |
| 07/05/2000 | EP1016419A2 Non-invasive localization of a light-emitting conjugate in a mammal |
| 07/05/2000 | EP1015586A2 Tie receptor tyrosine kinase ligand homologues |
| 07/05/2000 | EP1015585A2 Tie ligand homologues |
| 07/05/2000 | EP1015419A1 Polydentate imines and their metal complexes |
| 07/05/2000 | EP1015039A1 Oxygen delivery agents and uses for the same |
| 07/05/2000 | EP1015038A1 Methods for the detection, treatment, and prevention of neurodegeneration |
| 07/05/2000 | EP1014945A1 Cationic lipid compositions targeting angiogenic endothelial cells |
| 07/05/2000 | EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
| 07/05/2000 | EP0689461B1 Improvements in or relating to contrast agents |
| 07/05/2000 | EP0528891B1 Method for increasing blood-brain barrier permeability |
| 07/05/2000 | CN1054076C Chinese medicinal developing liquid for gastric ultrasonic B examination |
| 07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
| 07/04/2000 | US6084005 Antimicrobial caries-detecting composition |
| 07/04/2000 | US6083966 Thiazoline acid derivatives |
| 07/04/2000 | US6083936 Treatment of estrogen-dependent disorders such as estrogen-dependent cancers; also useful in diagnostic techniques such as magnetic resonance imaging and magnetic resonance spectroscopy |
| 07/04/2000 | US6083502 Methods for detecting the antigen and its expression level as an indication of the presence of tumor cells |
| 07/04/2000 | US6083501 Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases |
| 07/04/2000 | US6083486 Intramolecularly-quenched near infrared fluorescent probes |
| 07/04/2000 | US6083485 Near infrared radiation in-vivo diagnostic methods and dyes |
| 07/04/2000 | US6083484 Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents |
| 07/04/2000 | US6083480 Calcitonin receptor binding reagents |
| 07/04/2000 | US6083479 Use of tetraazamacrocycle compounds |
| 06/29/2000 | WO2000037938A1 FUNCTION-BASED SMALL MOLECULAR WEIGHT COMPOUND SCREENING SYSTEM IN $i(DROSOPHILA MELANOGASTER) |
| 06/29/2000 | WO2000037927A1 High energy phototherapeutic agents |
| 06/29/2000 | WO2000037115A1 Water-soluble contrast media for x-ray imaging |
| 06/29/2000 | WO2000037114A2 Methods and compositions comprising monitoring devices |
| 06/29/2000 | WO2000037112A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | WO1999049019A3 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 06/29/2000 | WO1998020909A3 Ex-corpore method for treating human blood cells |
| 06/29/2000 | CA2355879A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/28/2000 | EP1013285A2 Urokinase-type plasminogen activator receptor |
| 06/28/2000 | EP1012603A1 Functional fragments of hiv-1 vpr protein and methods of using the same |
| 06/28/2000 | EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 06/28/2000 | EP1011736A2 Polymers |
| 06/28/2000 | EP1011623A1 Wet appliable sunscreen and makeup and method for testing sunscreens for efficacy |
| 06/28/2000 | EP1011422A1 Imaging of light scattering tissues with fluorescent contrast agents |
| 06/28/2000 | EP1011415A1 Non-invasive method for diagnosing alzheimer's disease in a patient |
| 06/28/2000 | EP0815072B1 Radiographic contrasting agent for computerised tomography and urography |
| 06/28/2000 | CN1258198A Utilisations of oil bodies |
| 06/28/2000 | CN1053910C Method for synthesizing cyclic poly-amino poly-carboxylic acid chelate contrast medium |
| 06/27/2000 | US6080785 Reacting a alkylnedi-primary amine compound with a protective group such as trifluoroacetyl or benzyl group reagent to form an intermediate, reacting the intermediate with haloacetic tert-bytyl ester to form ester groups, deprotecting |
| 06/27/2000 | US6080386 Ultrasound imaging of myocardial, renal, or hepatic tissue by intravenously injecting echo contrast agent, compressing the microbubbles using ultrasonic field, temporarily allowing microbubbles to grow in size and recompressing to visualize |
| 06/27/2000 | US6080383 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer |
| 06/27/2000 | US6079213 Methods of collecting, thawing, and extending the useful life of polarized gases and associated accumulators and heating jackets |
| 06/22/2000 | WO2000036002A1 Plastic moulding materials which can be detected by x-ray contrast |
| 06/22/2000 | WO2000035950A2 Reagents and methods useful for detecting diseases of the breast |
| 06/22/2000 | WO2000035887A2 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | WO2000035493A2 Method for localizing a site of disease |
| 06/22/2000 | WO2000035492A2 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | WO2000035491A1 Monitoring gastrointestinal function to guide care of high risk patients |
| 06/22/2000 | WO2000035490A2 Contrast agent for facilitating ocular identification and inspection of lymph nodes |
| 06/22/2000 | WO2000035489A1 Magnetic resonance tomography contrast agent |
| 06/22/2000 | WO2000035488A2 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | WO2000035373A1 Methods for soft tissue augmentation |
| 06/22/2000 | WO2000035357A1 Methods and apparatus for enhancement of transdermal transport |
| 06/22/2000 | WO2000001350A3 Material for modifying the optical properties of different cells, device for applying such a material, diagnostic apparatus for determining the optical properties of cells and device for irradiating cells |
| 06/22/2000 | CA2727746A1 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | CA2355870A1 Reagents and methods useful for detecting diseases of the breast |
| 06/22/2000 | CA2355184A1 Methods and apparatus for enhancement of transdermal transport |
| 06/22/2000 | CA2353871A1 Magnetic resonance tomography contrast agent |
| 06/22/2000 | CA2353860A1 Plastic moulding materials which can be detected by x-ray contrast |
| 06/22/2000 | CA2349501A1 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | CA2349333A1 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | CA2346935A1 Vitronectin receptor antagonist pharmaceuticals |
| 06/21/2000 | EP1009772A1 Monoclonal antibodies that bind testosterone |
| 06/21/2000 | EP1009445A2 Particulate compositions |
| 06/21/2000 | DE19857618A1 Verfahren zur Lokalisierung von Krankheitsherden A process for the localization of disease sites |
| 06/21/2000 | CN1257479A Yellow polymorph of 5-amino-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)-isophthalamide |
| 06/20/2000 | US6077508 Administering a labeled molecule such as antibody that binds to a urokinase plasminogen activator receptor; delaying to allow labeled molecule to concentrate at metastatic lesion; detection above background level indicates metastatic lesion |
| 06/20/2000 | CA2000479C Vasopermeability-enhancing conjugates |
| 06/20/2000 | CA1341035C Macrocyclic polyaza compounds containing 5 or 6 membered rings, process for producing them and pharmaceutical media containing them. |
| 06/15/2000 | WO2000034459A1 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 06/15/2000 | WO2000033891A1 Methods for detection of vulnerable plaques using a detectable lipid-avid agent |
| 06/15/2000 | WO2000033890A1 Particulate radiopaque contrast agent for microvascular x-ray imaging |
| 06/15/2000 | WO2000015231A8 Adenosine a3 receptor modulators |
| 06/15/2000 | WO2000006244A3 Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
| 06/15/2000 | WO1999066951A3 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 06/15/2000 | WO1999045016A3 Novel prodrugs for phosphorus-containing compounds |
| 06/15/2000 | DE19857345A1 MRT-Kontrastmittel MRI contrast agent |
| 06/15/2000 | DE19857149A1 Röntgenkontrastierbare Kunststoffmassen Röntgenkontrastierbare plastic masses |
| 06/14/2000 | EP1008356A1 X-ray contrast media |
| 06/14/2000 | EP1007970A1 Diagnostic kit for skin tests, and method |
| 06/14/2000 | EP1007947A1 Method for detecting cancer on skin of humans and mammals and arrangement for performing the method |
| 06/14/2000 | EP1007699A1 Peptide-enhanced transfections |
| 06/14/2000 | EP1007628A1 Transgenic model for heart failure |